Caroline L Alvares

5PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCardiology (incl. cardiovascular diseases)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2026
Random Survival Forest Versus Elastic-Net Regularized Cox Regression for Survival Prediction in Acute Myeloid Leukemia at Distinct Treatment Time Points: Model Performance Comparison Study.

|Sep 19, 2024
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins.

Melisa Halilovic, Mohamed Abdelsalam, Joanna Zabkiewicz

|Nov 14, 2022
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.

Gonzalo Carreño-Tarragona, Alberto Álvarez-Larrán, Claire Harrison

|Oct 26, 2022
Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation.

Claudia Chiriches, Nathalie Nicolaisen, Maria Wieske

|May 13, 2020
Combination of a mitogen-activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion-based residual disease and prevents re-expansion of FLT3-ITD acute myeloid leukaemia.

Joanna Zabkiewicz, Michelle Lazenby, Gareth Edwards

Pageof 1

Frequent Collaborators

1 joint publications

Claudia Chiriches

1 joint publications

Nathalie Nicolaisen

1 joint publications

Maria Wieske

1 joint publications

Heba Elhaddad